MiMedx Group (MDXG) Reports Q4 EPS of 5c

MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.05, $0.03 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69.9 million versus the consensus estimate of $71.13 million.

GUIDANCE:

MiMedx Group sees FY2017 EPS of $0.31-$0.33, versus the consensus of $0.32. MiMedx Group sees FY2017 revenue of $302-307 million, versus the consensus of $304.8 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Constellation Brands (STZ) Tops Q1 EPS by 18c
• GNI Group acquires Ayumi Pharmaceutical for ¥44.8 billion